Endotoxin-independent white cell cytokine production in haemodynamically stable patients with idiopathic dilated cardiomyopathy

Cardiovascular Journal of South Africa

Volumn 16, Issue 5, 2005, Pages 260-265

  Brooksbank, Richard ^a   Woodiwiss, Angela J ^a   Sliwa, Karen ^a   Badenhorst, Danelle ^a   Deftereos, Dawn ^a   Wadee, Ahmed A ^a   Essop, Mohammed R ^a   Sareli, Pinhas ^a   Norton, Gavin R ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN A; CYTOKINE; ENDOTOXIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CELL CULTURE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EDEMA; FEMALE; HEART FAILURE; HEART FUNCTION; HEMODYNAMICS; HUMAN; IDIOPATHIC DISEASE; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LEUKOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; PROTEIN BLOOD LEVEL; STIMULUS;

CARDIOMYOPATHY, DILATED; ENDOTOXINS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEUKOCYTES; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 29044438579     PISSN: 10159657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Levine B, Kalman J, Mayer L, Fiuit HM, Packer M. Elevated circulating levels of tumor necrosis factor alpha in severe chronic heart failure. N. Engl. J. Med 1983; 323: 236-241.
2. Mann DL, Young JB. Basic mechanisms in congestive heart failure. Recognizing the role of pro-inflammatory cytokines. Chest 1994; 105: 897-904.
3. Matsumori A, Yamada T, Suzuki H, et al. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994; 72: 561-566.
4. Seta Y, Shan K, Bozkurt B, et al. Basic mechanisms in heart failure: the cytokine hypothesis. J Cardiac Failure 1996; 2: 243-249.
5. Torre-Amione G, Capaslera S, Benedict C, et al. Pro-inflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996; 27: 1201-1206.
6. Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factor and tumor necrosis factor receptors in the failing human heart. Circulation 1996; 93: 704-711.
7. Kelly RA, Smith TW. Cytokines and cardiac contractile function. Circulation 1997; 95: 778-781.
8. Anker SD, Coats AJ. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int J Cardiol 2002; 86: 123-130.
9. Mann DL. Inflammatory mediators and the failing heart: past, present and the foreseeable future. Circ Res 2002; 91: 988-998.
10. Keith M, Geranmayegan A, Sole MJ. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 1998; 31: 1352-1356.
11. Anker SD, Egerer KR, Volle HD, et al. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 1999; 79: 1426-1429.
12. Niebauer J, Volk HD, Kemp M, et al. Endotoxin and immune activation in chrome heart failure: a prospective cohort study. Lancet 1999; 353: 1838-1842.
13. Genth-Zotz S, von Haehling, S, Bolger AP, et al. Pathophysiologic quantities of endotoxin induce tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure. Am J Cardiol 2002; 90: 1226-1422.
14. Doyama K, Fujiwara H, Fukimoto M, et al. Tumor necrosis factor is expressed in the cardiac tissues of patients with heart failure. Int J Cardiol 1996; 31: 391-398.
15. Habib FM, Springall DR, Davies GJ, et al. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 1996; 347: 1151-1155.
16. Kalra D, Sivasubramanian N, Mann DL. Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase-C dependent pathway. Circulation 2002; 105: 2198-2205.
17. Mann DL. Inflammatory mediators in heart failure: homogeneity through heterogeneity. Lancet 1999; 353: 1812-1813.
18. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992; 20: 248-254.
19. Torre-Amione G, Kapadia S, Lee J, et al. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995; 92: 1487-1493.
20. Mobini R, Maschke H, Waagstein F. New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy. Autoimmun Rev 2004; 4: 277-284
21. Dorffel WV, Wallukat G, Dorffel Y, Felix SB, Baumann G. Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up. Int J Cardiol 2004; 3: 529-534.
22. Lupi P, Rudert WA, Zanone MM, et al. Idiopathic dilated cardiomyopathy: A superantigen-driven autoimmune disease. Circulation 1998; 98: 777-785.
23. Liu PP, Mason JW. Advances in understanding myocarditis. Circulation 2001; 104: 1076-1082.
24. Aukrust P, Veland T, Lien E, et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1999; 83: 376-382.
25. Candy GP, Skudicky D, Mueller UK, et al. Association of left ventricular systolic performance and cavity size with angiotensin-converting enzyme genotype in idiopathic dilated cardiomyopathy. Am J Cardiol 1999; 83: 740-744.
26. Halloran P.F. Molecular mechanisms of new immunosuppressents. Clin Transplantation 1996; 83: 740-744.
27. +-ATPase modulate macrophage effector functions. Proc Natl Acad Sci (USA) 1999; 11: 6324-6329.